Updates are available Correction dated 2020-09-02
Click to view Correction: https://doi.org/10.1007/s10067-020-05356-1
-
Authors
Lau, Chak Sing http://orcid.org/0000-0001-6698-8355
Chen, Yi-Hsing
Lim, Keith
de Longueville, Marc
Arendt, Catherine
Winthrop, Kevin
-
Funding
Funding for this research was provided by:
UCB Pharma
- License Information
-
More Information
Article History
Received: 1 April 2020
Revised: 13 June 2020
Accepted: 18 June 2020
First Online: 1 August 2020
Change Date: 19 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10067-020-05356-1
Compliance with ethical standards
:
: CSL: Consulting fees from UCB Pharma; YHC: Consulting fees from UCB Pharma; KL: Consulting fees from UCB Pharma; MdL: Former employee of UCB Pharma; CA: Employee of UCB Pharma; KW: Consulting fees from AbbVie, Bristol-Myers Squibb, Eli-Lilly, Roche, Pfizer, and UCB Pharma.
: Ethical approval and patient consent were obtained for all clinical trials involved. All clinical trials complied with the Declaration of Helsinki. Additional ethical approval was not required for this study as all analyses are post hoc.
: Patients’ consent was received for all clinical trials and NIS included in these analyses. Patient consent to participate was not required for this study as all analyses are post hoc and data are fully anonymized.
: Patients’ consent was received for all clinical trials and NIS included in these analyses. Patient consent for publication was not required for this study as all analyses are post hoc and data are fully anonymized.
